Excellent 12-month results from SELUTION SFA trial presented at JET

12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was

Related Keywords

Tokyo ,Japan ,United States ,Switzerland ,Osaka ,Nyon ,Switzerland General ,Japanese ,Richard Kenyonmedalliance ,Osamu Iida ,Cell Adherent Technology ,Osaka Police Hospital Cardiovascular Center ,Japan Endovascular Treatment ,Prof Zeller ,Middle East ,Computer Services News ,Eluting ,Aclitaxel Without ,Resented ,Approval For ,Concerns ,Release ,Artery ,Trials ,